In a groundbreaking move for the healthcare sector, Abu Dhabi University has embarked on a mission to make cochlear implants more affordable for individuals with hearing loss in the UAE. The initiative, named the UAE Hears the World Initiative, is a collaborative effort with Swiss company Neubio, renowned for its electronic-free earpieces.
The agreement between Abu Dhabi University and Neubio aims to revolutionize the availability of cochlear implants in the Gulf Cooperation Council (GCC) countries, Egypt, and Algeria. By leveraging Neubio’s expertise and innovative technology, the initiative seeks to significantly lower the cost of cochlear implants, which traditionally range from $27,000 to $68,000 in the UAE.
Under the UAE Hears the World Initiative, Abu Dhabi University and Neubio will work together to produce cochlear implants domestically, with the goal of reducing the price to a more affordable range of $10,000 to $12,000. This move is poised to make cochlear implants accessible to a broader segment of the population, addressing the pressing need for affordable hearing solutions in the region.
Dr. Montasir Qasymeh, Associate Provost for Research, Innovation, and Academic Development at Abu Dhabi University, expressed optimism about the initiative’s potential impact. He emphasized the importance of collaboration with governmental entities to bring new technology to the forefront of healthcare in the UAE. Dr. Qasymeh highlighted the significance of this partnership, which represents a convergence of academia, industry, and government support for healthcare innovation.
The UAE Hears the World Initiative, launched in February, underscores the commitment of Abu Dhabi University and Neubio to address the global challenge of hearing loss. By producing electronic-free cochlear implants locally, the initiative aims to mitigate the risks associated with electronic failure and reduce the need for revision surgery. Additionally, the compact design of the implants offers greater flexibility during surgical procedures, ultimately enhancing patient outcomes.
Joshua Chang, Director of Global Impact at Neubio, emphasized the humanitarian aspect of the initiative. He underscored the company’s commitment to making hearing solutions accessible to individuals regardless of their economic status. By offering cochlear implants at a significantly reduced cost, Neubio aims to break free from the constraints of high-cost devices and ensure that advanced technology is available to those in need.
The collaboration between Abu Dhabi University and Neubio represents a significant step forward in healthcare innovation in the UAE. By harnessing Swiss technology and local production capabilities, the initiative aims to address the growing demand for affordable cochlear implants in the region. As the project progresses, stakeholders anticipate broader access to hearing rehabilitation services and improved quality of life for individuals with hearing loss.
In conclusion, the partnership between Abu Dhabi University and Neubio heralds a new era of accessibility and affordability in hearing healthcare in the UAE. Through the UAE Hears the World Initiative, the two entities are poised to make a meaningful impact on the lives of individuals with hearing impairment, demonstrating the power of collaboration in driving healthcare innovation.
